1 / 6

Non-Invasive Prenatal Testing Global Market Industry Insights

North America dominates the NIPT market owing to the rising incidences of genetic disorders in newborns, increasing awareness about NIPT, technological development in NIPT technologies, and increased spending on R&D activities will fuel the growth in the region. <br><br>Pacific Biosciences of California, Inc., has acquired Omniome, to expand its market opportunities for sequencing innovative ways and add value to customers. Omnium has a novel approach to have an accurate short-read sequencing platform and enter large, fast-growing clinical applications such as oncology and non-invasive prenatal test

Research1
Download Presentation

Non-Invasive Prenatal Testing Global Market Industry Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Non-Invasive Prenatal Testing Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Non-Invasive Prenatal Testing Market Owing to technological development and decreasing cost of genetic testing, the NIPT market will grow significantly at 16.35% CAGR due to the availability of more genetic conditions. Non-Invasive Prenatal testing is widely adopted in the testing of common chromosomal aneuploidies and medical professionals believe that NIPT can be adopted in routine antenatal care. The increasing prominence among pregnant women as it involves less risk in comparison to amniocentesis and increasing awareness about prenatal genetic issues will drive the growth of the global non-invasive prenatal testing (NIPT) market. The rising cases of miscarriage and complications will lead to a standard test in the future as it provides the precision of more than 99% and provides screening display in less time will create growth in the global non-invasive prenatal testing (NIPT) market.

  4. Global Non-Invasive Prenatal Testing Market The COVID-19 impact has a limited effect on the non-invasive prenatal testing market. According to the report by SeraCare, in-vitro diagnostics manufacturers and clinical testing laboratories have collaborated with research organisations to find out the SARS-CoV-2 infection on pregnant ladies and congenital disabilities in new-born. So there is a need for NIPT during COVID-19 outbreak. Based on end-user, diagnostic laboratories dominate the NIPT market as there is a rising preference for using NIPT services of diagnostic laboratories by gynecologists and patients. Moreover, diagnostics labs have a well-equipped facility and skilled laboratory technicians resulting in a huge volume of tests being outsourced, thereby driving the growth of the market.

  5. Global Non-Invasive Prenatal Testing Market North America dominates the NIPT market owing to the rising incidences of genetic disorders in newborns, increasing awareness about NIPT, technological development in NIPT technologies, and increased spending on R&D activities will fuel the growth in the region. Pacific Biosciences of California, Inc., has acquired Omniome, to expand its market opportunities for sequencing innovative ways and add value to customers. Omniome has a novel approach to have an accurate short-read sequencing platform and enter large, fast-growing clinical applications such as oncology and non-invasive prenatal testing. The prominent players in the NIPT industry include GE Healthcare, Perkinelmer, Inc., Koninklijke N.V., Qiagen, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., and Beijing Genomics Institute.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample www.vynzresearch.com

More Related